Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Medicare Regs Likely To Define 15-17 Regions For Plans

This article was originally published in The Pink Sheet Daily

Executive Summary

HHS is likely to define 15-17 regions for the Medicare prescription drug benefit in regulations coming out this year, former Centers for Medicare & Medicaid Services Administrator Tom Scully said

You may also be interested in...



Medicare Rx Regional Map Proposals Unveiled Ahead Of CMS Workshop

A CMS contractor has analyzed six different maps for Part D and five for Medicare Advantage to stimulate public comment. If CMS wants to choose one structure for both programs, 11 regions may be the magic number.

Medicare Rx Regional Map Proposals Unveiled Ahead Of CMS Workshop

A CMS contractor has analyzed six different maps for Part D and five for Medicare Advantage to stimulate public comment. If CMS wants to choose one structure for both programs, 11 regions may be the magic number.

Medicare Rx Implementing Regs Expected After July 4

CMS is understood to be nearing completion on Title II (Medicare Advantage) regs. However, the current plan is to release Title I (Medicare Part D) and Title II on the same day.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059439

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel